Randomized Trial of Heat Recovery Ventilators (HRVs) for the Prevention of Severe Lower Respiratory Tract Infection (LRTI) in Inuit Infants in Baffin Region, Nunavut, Canada

ISRCTN ISRCTN71224182
DOI https://doi.org/10.1186/ISRCTN71224182
Protocol serial number PERD-089
Sponsor Program of Energy Research and Development (Canada)
Funder Program of Energy Research and Development (PERD) PERD-089
Submission date
15/08/2005
Registration date
04/11/2005
Last edited
09/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Thomas Kovesi
Scientific

Children's Hospital of Eastern Ontario
401 Smyth Rd
Ottawa
K1H 8L1
Canada

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleRandomized Trial of Heat Recovery Ventilators (HRVs) for the Prevention of Severe Lower Respiratory Tract Infection (LRTI) in Inuit Infants in Baffin Region, Nunavut, Canada
Study objectivesHeat Recovery Ventilators, by improving indoor air ventilation and indoor air quality will reduce the incidence of severe lower respiratory tract infection requiring admission to hospital in Inuit infants in Baffin Region, Nunavut.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBronchiolitis, Pneumonia
InterventionHeat Recovery Ventilator versus placebo Heat Recovery Ventilator
Intervention typeOther
Primary outcome measure(s)

Admission to hospital for severe lower respiratory tract infection

Key secondary outcome measure(s)

Effect of Heat Recovery Ventilators on indoor CO2, Air change rate, respiratory symptoms, occupant comfort, and visits to the nursing station for respiratory illness.

Completion date15/09/2008

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit0 Years
Upper age limit2 Years
SexAll
Target sample size at registration150
Total final enrolment68
Key inclusion criteriaInuit infants 0-2 years of age living in eligible communities in Baffin Region, Nunavut, Canada
Key exclusion criteriaChildren with underlying congenital malformations known to increase the risk of LRTI, including congenital lung malformations and congenital heart disease will be excluded from the study, as well as children with underlying conditions known to increase the risk of LRTI, including cystic fibrosis, severe developmental delay, and immunodeficiency. Houses where it is technically impossible to install the HRV will be excluded from the study. Only households providing informed consent will be allowed to participate in the trial.
Date of first enrolment15/09/2005
Date of final enrolment15/09/2008

Locations

Countries of recruitment

  • Canada

Study participating centre

Children's Hospital of Eastern Ontario
Ottawa
K1H 8L1
Canada

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2009 09/05/2019 Yes No

Editorial Notes

09/05/2019: Publication reference and total final enrolment added.